Passage Bio (PASG) Earnings Date & Reports

Passage Bio Inc is a genetic medicines company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PASG is expected to report earnings to rise 25.00% to -25 cents per share on May 19

Q1'25

Est.

$-0.25

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.08

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.05

The last earnings report on March 04 showed earnings per share of -20 cents, beating the estimate of -22 cents. With 172.01K shares outstanding, the current market capitalization sits at 21.75M.

View a ticker or compare two or three

Compare

PASG

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PASG
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2005 Market Street

Phone

+1 267 866-0311

Employees

Web

https://www.passagebio.com